August 2, 2024
Health Canada grants approval for Celltrion’s Steqeyma for multiple conditions
Health Canada has granted approval for Celltrion Healthcare Canada’s Steqeyma (ustekinumab injection) and Steqeyma IV (ustekinumab for injection, solution for intravenous infusion) for treating various chronic inflammatory conditions.